HealthQuill Uncategorized
Bionomics Limited, a clinical-stage biotechnology company announced positive outcomes for its experimental drug to treat post-traumatic stress disorder (PTSD).
Uncategorized

ADHD medication linked to lower risk of suicidal behaviour, study finds

August 14, 2025: A new study conducted by researchers at the University of Southampton in the UK and the Karolinska Institute in Sweden.

Read More
Bristol Myers Squibb, a New Jersey-based drugmaker, announced it has met its primary goal of improved overall survival for its investigational therapy to treat liver cancer.
Uncategorized

Bayer and Kumquat Biosciences ink $1.3 billion deal to develop cancer inhibitor

HQ Team August 13, 2025: Bayer and Kumquat Biosciences, a clinical-stage biotech, announced an exclusive global license and collaboration agreement worth $1.3 billion.

Read More
AbbVie Inc. will buy Capstan Therapeutics, Inc., a clinical-stage biotechnology company, for $2.1 billion in cash to acquire the latter’s investigational medicine to treat autoimmune diseases and its delivery technology.
Uncategorized

AbbVie to acquire Capstan for $2.1b, gets experimental drug, technology 

HQ Team June 30, 2025: AbbVie Inc. will buy Capstan Therapeutics, Inc., a clinical-stage biotechnology company, for $2.1 billion in cash to acquire.

Read More
Gilead Sciences, Inc.’s twice-yearly injectable drug for the prevention of HIV in adults and adolescents got approval from the US regulator.
Uncategorized

Gilead’s Yeztugo drug for HIV prevention in adults gets FDA nod

HQ Team June 19, 2025: Gilead Sciences, Inc.’s twice-yearly injectable drug for the prevention of HIV in adults and adolescents got approval from.

Read More
Stanford University researchers have developed a gene-editing technology, which they hope will lead to treatments for neurological diseases as well as traumatic injury.
Uncategorized

‘Mailman’ gene-editing tool carries molecule to exact ‘zip code’

HQ Team May 24, 2025: Stanford University researchers have developed a gene-editing technology, which they hope will lead to treatments for neurological diseases.

Read More
FDA has granted full approval for Janssen Biotech’s Balversa drug to treat metastatic bladder cancer after clinical trials showed “significant” improvement in overall survival rates.
Uncategorized

Study sees rising cancer cases in young adults; death rates remain stable

HQ Team May 8, 2025: In a surprising and concerning trend, new research from the National Institutes of Health (NIH) reveals that 14 types of cancer are.

Read More
Pfizer Inc. stopped its trial of danuglipron for treating chronic weight management after an asymptomatic patient developed a drug-induced liver injury that was resolved after discontinuation of the oral drug.
Uncategorized

Pfizer stops development of an investigational drug to treat obesity

HQ Team April 15, 2025: Pfizer Inc. stopped its trial of danuglipron for treating chronic weight management after an asymptomatic patient developed a.

Read More
Sonia Vallabh, a graduate of Harvard Law School and her husband  Eric Minikel, who holds a planning degree from MIT, re-engineered their careers to do research into prion disease when she was diagnosed with the disorder. Now their research may lead to a treatment if not a cure in the not-too-distant future, according to a statement from Harvard.
Uncategorized

Patient-scientist behind new gene-editing tool for prion disease

HQ Team April 10, 2025:  Sonia Vallabh, a graduate of Harvard Law School and her husband  Eric Minikel, who holds a planning degree.

Read More
Scientists have converted cancer cells to healthy ones to treat a devastating pediatric cancer through a method called differentiation therapy.
Uncategorized

Scientists discover key protein AP2A1 that reverses cellular aging

HQ Team   February 20, 2025 – Researchers from Osaka University have identified a protein, AP2A1, that could hold the key to reversing.

Read More
Georgia Tech researchers have developed a prototype 3D-printed, bioresorbable heart valve that promotes tissue regeneration, potentially eliminating the need for repeated surgeries for adult and pediatric heart patients, according to a statement.
Uncategorized

US scientists make heart valves to aid tissue regeneration, avoid surgeries

Georgia Tech researchers have developed a prototype 3D-printed, bioresorbable heart valve that promotes tissue regeneration, potentially eliminating the need for repeated surgeries for.

Read More